NCT06415175 - Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

November 23, 2027

Conditions

Atopic Dermatitis

Interventions

DRUG

Dupilumab

This study will not administer any treatment, only observe the treatment as prescribed in real world-clinical practice.

Trial Locations (15)

15706

RECRUITING

Investigational Site Number : 7240004, Santiago de Compostela

28007

RECRUITING

Investigational Site Number : 7240001, Madrid

28009

RECRUITING

Investigational Site Number : 7240010, Madrid

28031

RECRUITING

Investigational Site Number : 7240007, Madrid

28046

RECRUITING

Investigational Site Number : 7240014, Madrid

29010

RECRUITING

Investigational Site Number : 7240013, Málaga

33011

RECRUITING

Investigational Site Number : 7240005, Oviedo

38320

RECRUITING

Investigational Site Number : 7240009, San Cristóbal de La Laguna

41013

RECRUITING

Investigational Site Number : 7240008, Seville

46026

RECRUITING

Investigational Site Number : 7240016, Valencia

50009

RECRUITING

Investigational Site Number : 7240011, Zaragoza

08950

RECRUITING

Investigational Site Number : 7240006, Esplugues de Llobregat

03010

RECRUITING

Investigational Site Number : 7240002, Alicante

08041

RECRUITING

Investigational Site Number : 7240003, Barcelona

07120

RECRUITING

Investigational Site Number : 7240012, Palma